Advertisement

Topics

Pfizer Says FDA Accepts Regulatory Submissions For Review Of Tafamidis

08:25 EST 14 Jan 2019 | FinanzNachrichten

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) said that the US Food and Drug Administration accepted for filing the company's New Drug Applications or NDAs for tafamidis for the treatment of transth...

Original Article: Pfizer Says FDA Accepts Regulatory Submissions For Review Of Tafamidis

NEXT ARTICLE

More From BioPortfolio on "Pfizer Says FDA Accepts Regulatory Submissions For Review Of Tafamidis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...